Autologous blood donation

被引:21
作者
Goodnough, LT [1 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO 63110 USA
[2] Barnes Jewish Hosp, Transfus Serv, St Louis, MO 63110 USA
来源
CRITICAL CARE | 2004年 / 8卷 / Suppl 2期
关键词
autologous blood donation; blood transfusion; elective surgery;
D O I
10.1186/cc2408
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Although preoperative autologous blood donation is employed in elective surgery, this is declining because of the increasingly safe allogeneic blood supply. However, it continues to be used because of the public's perception of allogeneic blood risks and increasing blood shortages. Patients may donate a unit of blood (450+/-45 ml) as often as twice weekly, up to 72 hours before surgery. Preoperative autologous blood is most beneficial in procedures that cause significant blood loss, It has been determined that preoperative autologous blood donation is poorly cost-effective; the use of this procedure must be based on evidence that it is safe and of value for the patient.
引用
收藏
页码:S49 / S52
页数:4
相关论文
共 25 条
[1]
An analysis of blood management in patients having a total hip or knee arthroplasty [J].
Bierbaum, BE ;
Callaghan, JJ ;
Galante, JO ;
Rubash, HE ;
Tooms, RE ;
Welch, RB .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1999, 81A (01) :2-10
[2]
THE COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS BLOOD DONATION FOR TOTAL HIP AND KNEE REPLACEMENT [J].
BIRKMEYER, JD ;
GOODNOUGH, LT ;
AUBUCHON, JP ;
NOORDSIJ, PG ;
LITTENBERG, B .
TRANSFUSION, 1993, 33 (07) :544-551
[3]
COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS DONATION IN CORONARY-ARTERY BYPASS-GRAFTING [J].
BIRKMEYER, JD ;
AUBUCHON, JP ;
LITTENBERG, B ;
OCONNOR, GT ;
NEASE, RF ;
NUGENT, WC ;
GOODNOUGH, LT .
ANNALS OF THORACIC SURGERY, 1994, 57 (01) :161-169
[4]
THE COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS BLOOD DONATIONS [J].
ETCHASON, J ;
PETZ, L ;
KEELER, E ;
CALHOUN, L ;
KLEINMAN, S ;
SNIDER, C ;
FINK, A ;
BROOK, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) :719-724
[5]
Public perception of the risk of blood transfusion [J].
Finucane, ML ;
Slovic, P ;
Mertz, CK .
TRANSFUSION, 2000, 40 (08) :1017-1022
[6]
Goodnough Lawrence T., 1996, American Journal of Medicine, V101, p33S, DOI 10.1016/S0002-9343(96)00167-2
[7]
Medical progress - Transfusion medicine - Second of two parts - Blood conservation [J].
Goodnough, LT ;
Brecher, ME ;
Kanter, MH ;
AuBuchon, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (07) :525-533
[8]
A PHASE-III TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN NONANEMIC ORTHOPEDIC PATIENTS SUBJECTED TO AGGRESSIVE REMOVAL OF BLOOD FOR AUTOLOGOUS USE - DOSE, RESPONSE, TOXICITY, AND EFFICACY [J].
GOODNOUGH, LT ;
PRICE, TH ;
FRIEDMAN, KD ;
JOHNSTON, M ;
CIAVARELLA, D ;
KHAN, N ;
SACHER, R ;
VOGLER, WR ;
WISSEL, M ;
ABELS, RI .
TRANSFUSION, 1994, 34 (01) :66-71
[9]
Current concepts: Erythropoietin therapy [J].
Goodnough, LT ;
Monk, TG ;
Andriole, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :933-938
[10]
PREOPERATIVE RED-CELL PRODUCTION IN PATIENTS UNDERGOING AGGRESSIVE AUTOLOGOUS BLOOD PHLEBOTOMY WITH AND WITHOUT ERYTHROPOIETIN THERAPY [J].
GOODNOUGH, LT ;
PRICE, TH ;
RUDNICK, S ;
SOEGIARSO, RW .
TRANSFUSION, 1992, 32 (05) :441-445